Interventional approaches to mitral regurgitation
详细信息 查看全文
- 作者：V. Mauri ; S. Baldus ; Prof. Dr. med. V. Rudolph
- 关键词：Mitral regurgitation ; Transcatheter mitral valve repair ; Transcatheter mitral valve replacement ; MitraClip ; Review
- 刊名：Herz
- 出版年：2016
- 出版时间：February 2016
- 年：2016
- 卷：41
- 期：1
- 页码：26-30
- 全文大小：5,180 KB
- 参考文献：1.Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M (2006) Burden of valvular heart diseases: a population-based study. Lancet 368(9540):1005–1011. doi:10.1016/S0140-6736(06)69208-8 CrossRef PubMed
2.Enriquez-Sarano M, Akins CW, Vahanian A (2009) Mitral regurgitation. Lancet 373(9672):1382–1394. doi:10.1016/S0140-6736(09)60692-9 CrossRef PubMed
3.Ling LH, Enriquez-Sarano M, Seward JB, Tajik AJ, Schaff HV, Bailey KR, Frye RL (1996) Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 335(19):1417–1423. doi:10.1056/NEJM199611073351902 CrossRef PubMed
4.Gammie JS, Sheng S, Griffith BP, Peterson ED, Rankin JS, O’Brien SM, Brown JM (2009) Trends in mitral valve surgery in the United States: results from the Society of Thoracic Surgeons Adult Cardiac Database. Ann Thorac Surg 87(5):1431–1439. doi:10.1016/j.athoracsur.2009.01.064 CrossRef PubMed
5.Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM (2005) Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 45(3):381–387. doi:10.1016/j.jacc.2004.09.073 CrossRef PubMed
6.Diodato MD, Moon MR, Pasque MK, Barner HB, Moazami N, Lawton JS, Bailey MS, Guthrie TJ, Meyers BF, Damiano RJ Jr (2004) Repair of ischemic mitral regurgitation does not increase mortality or improve long-term survival in patients undergoing coronary artery revascularization: a propensity analysis. Ann Thorac Surg 78(3):794–799. doi:10.1016/j.athoracsur.2004.03.022 CrossRef PubMed
7.Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Detaint D, Vanoverschelde JL, Butchart EG, Ravaud P, Vahanian A (2007) What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 28(11):1358–1365. doi:10.1093/eurheartj/ehm001 CrossRef PubMed
8.Thyregod HG, Steinbruchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, Chang Y, Franzen OW, Engstrom T, Clemmensen P, Hansen PB, Andersen LW, Olsen PS, Sondergaard L (2015) Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol 65(20):2184–2194. doi:10.1016/j.jacc.2015.03.014 CrossRef PubMed
9.Grasso C, Baldus S (2015) The MitraClip transcatheter mitral valve repair system. EuroIntervention 11(Suppl W):W45–W46. doi:10.4244/EIJV11SWA11 CrossRef PubMed
10.Siminiak T, Wu JC, Haude M, Hoppe UC, Sadowski J, Lipiecki J, Fajadet J, Shah AM, Feldman T, Kaye DM, Goldberg SL, Levy WC, Solomon SD, Reuter DG (2012) Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial. Eur J Heart Fail 14(8):931–938. doi:10.1093/eurjhf/hfs076 PubMedCentral CrossRef PubMed
11.Schofer J, Siminiak T, Haude M, Herrman JP, Vainer J, Wu JC, Levy WC, Mauri L, Feldman T, Kwong RY, Kaye DM, Duffy SJ, Tubler T, Degen H, Brandt MC, Van Bibber R, Goldberg S, Reuter DG, Hoppe UC (2009) Percutaneous mitral annuloplasty for functional mitral regurgitation: results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation 120(4):326–333. doi:10.1161/CIRCULATIONAHA.109.849885 PubMedCentral CrossRef PubMed
12.Maisano F, La Canna G, Latib A, Denti P, Taramasso M, Kuck KH, Colombo A, Alfieri O, Guidotti A, Messika-Zeitoun D, Vahanian A (2014) First-in-man transseptal implantation of a “surgical-like” mitral valve annuloplasty device for functional mitral regurgitation. JACC Cardiovasc Interv 7(11):1326–1328. doi:10.1016/j.jcin.2014.08.003 CrossRef PubMed
13.Maisano F, Taramasso M (2015) The Cardioband transcatheter direct mitral valve annuloplasty system. EuroIntervention 11(Suppl W):W58–59. doi:10.4244/EIJV11SWA15 CrossRef PubMed
14.Siminiak T, Dankowski R, Baszko A, Lee C, Firek L, Kalmucki P, Szyszka A, Groothuis A (2013) Percutaneous direct mitral annuloplasty using the Mitralign Bident system: description of the method and a case report. Kardiol Pol 71(12):1287–1292. doi:10.5603/KP.2013.0325 CrossRef PubMed
15.Rogers JH, Thomas M, Morice MC, Narbute I, Zabunova M, Hovasse T, Poupineau M, Rudzitis A, Kamzola G, Zvaigzne L, Greene S, Erglis A (2015) Treatment of heart failure with associated functional mitral regurgitation using the ARTO System: initial results of the First-in-Human MAVERIC Trial (Mitral Valve Repair Clinical Trial). JACC Cardiovasc Interv 8(8):1095–1104. doi:10.1016/j.jcin.2015.04.012 CrossRef PubMed
16.Maisano F, Cioni M, Seeburger J, Falk V, Mohr FW, Mack MJ, Alfieri O, Vanermen H (2011) Beating-heart implantation of adjustable length mitral valve chordae: acute and chronic experience in an animal model. Eur J Cardiothorac Surg 40(4):840–847. doi:10.1016/j.ejcts.2011.01.021 PubMed
17.Seeburger J, Rinaldi M, Nielsen SL, Salizzoni S, Lange R, Schoenburg M, Alfieri O, Borger MA, Mohr FW, Aidietis A (2014) Off-pump transapical implantation of artificial neo-chordae to correct mitral regurgitation: the TACT Trial (Transapical Artificial Chordae Tendinae) proof of concept. J Am Coll Cardiol 63(9):914–919. doi:10.1016/j.jacc.2013.07.090 CrossRef PubMed
18.Rucinskas K, Janusauskas V, Zakarkaite D, Aidietiene S, Samalavicius R, Speziali G, Aidietis A (2014) Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: early results of a single-center experience. J Thorac Cardiovasc Surg 147(1):95–99. doi:10.1016/j.jtcvs.2013.08.012 CrossRef PubMed
19.Raval J, Nagaraja V, Eslick GD, Denniss AR (2014) Transcatheter valve-in-valve implantation: a systematic review of literature. Heart Lung Circ 23(11):1020–1028. doi:10.1016/j.hlc.2014.06.001 CrossRef PubMed
20.Hasan R, Mahadevan VS, Schneider H, Clarke B (2013) First in human transapical implantation of an inverted transcatheter aortic valve prosthesis to treat native mitral valve stenosis. Circulation 128(6):e74–e76. doi:10.1161/CIRCULATIONAHA.113.001466 CrossRef PubMed
21.Fassa AA, Himbert D, Brochet E, Depoix JP, Cheong AP, Alkhoder S, Nataf P, Vahanian A (2014) Transseptal transcatheter mitral valve implantation for severely calcified mitral stenosis. JACC Cardiovasc Interv 7(6):696–697. doi:10.1016/j.jcin.2013.12.204 CrossRef PubMed
22.Nielsen NE, Baranowski J, Ahn HC (2015) Transvenous Implantation of a Stent Valve for Calcified Native Mitral Stenosis. Ann Thorac Surg 100(1):e21–e23. doi:10.1016/j.athoracsur.2015.03.114 CrossRef PubMed
23.Guerrero M, Greenbaum A, O’Neill W (2014) First in human percutaneous implantation of a balloon expandable transcatheter heart valve in a severely stenosed native mitral valve. Catheter Cardiovasc Interv 83(7):E287–E291. doi:10.1002/ccd.25441 CrossRef PubMed
24.Cheung A, Webb J, Verheye S, Moss R, Boone R, Leipsic J, Ree R, Banai S (2014) Short-term results of transapical transcatheter mitral valve implantation for mitral regurgitation. J Am Coll Cardiol 64(17):1814–1819. doi:10.1016/j.jacc.2014.06.1208 CrossRef PubMed
25.Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, Carrel T, Praz F, Rajani R, Fam N, Kim H, Redwood S, Young C, Munns C, Windecker S, Thomas M (2014) Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device. EuroIntervention 10(Suppl U):U120–U128. doi:10.4244/EIJV10SUA18 CrossRef PubMed
26.Cheung A, Stub D, Moss R, Boone RH, Leipsic J, Verheye S, Banai S, Webb J (2014) Transcatheter mitral valve implantation with Tiara bioprosthesis. EuroIntervention 10(Suppl U):U115–119. doi:10.4244/EIJV10SUA17 CrossRef PubMed
27.Moat N, Duncan A, Lindsay A, Quarto C, Blanke P, Leipsic J, Grayburn P, Davies S (2015) Transcatheter mitral valve replacement for the treatment of mitral regurgitation: in-hospital outcomes of an apically tethered device. J Am Coll Cardiol 65(21):2352–2353. doi:10.1016/j.jacc.2015.01.066 CrossRef PubMed
28.Ussia GP, Quadri A, Cammalleri V, De Vico P, Muscoli S, Marchei M, Ruvolo G, Sondergaard L, Romeo F (2015) Percutaneous transfemoral-transseptal implantation of a second-generation CardiAQ mitral valve bioprosthesis: first procedure description and 30-day follow-up. EuroIntervention 11(5). doi:10.4244/EIJY15M09_01 - 作者单位：V. Mauri (1)
S. Baldus (1)
Prof. Dr. med. V. Rudolph (1)
1. Klinik für Kardiologie, Pneumologie, Angiologie und internistische Intensivmedizin, Herzzentrum Uniklinik Köln, Klinik III für Innere Medizin, Kerpener Str. 62, 50937, Cologne, Germany - 刊物类别：Medicine
- 刊物主题：Medicine & Public Health
Cardiology - 出版者：Urban & Vogel
- ISSN：1615-6692
文摘
Mitral regurgitation (MR) is the most prevalent valvular heart disease in the Western world. Surgical repair is the gold standard for the treatment of degenerative MR in low-risk patients. Given the rising number of patients with functional MR and higher operative risk due to relevant comorbidities and increasing age, interventional approaches to repair or replace diseased mitral valves are on the rise. However, the complex anatomy and physiology of the mitral valve and its adjacent valve apparatus bear major challenges. To date, only the MitraClip device has been used in a large number of patients; however, several other devices and systems specifically targeted at different underlying pathologies of MR are currently under development. In addition to valve repair, the first steps toward mitral valve replacement have been taken. The present article reviews the current state of the art of interventional approaches to mitral valve disease and its future perspectives.